US Broker Ratings

Verastem, Inc. (VSTM) Stock Analysis: Exploring a 147% Potential Upside in the Biotech Arena

Investors eyeing the biotechnology sector should take a closer look at Verastem, Inc. (NASDAQ: VSTM). With a market capitalization of approximately $339.04 million, Verastem is a..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a Potential 100% Upside in the Biopharmaceutical Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the biopharmaceutical sector, is capturing investor attention with a compelling potential upside of 100.81%, according to analyst..

Cogent Biosciences, Inc. (COGT)

⚠️ No article content returned.

..

iRadimed Corporation (IRMD) Stock Analysis: A 21.7% Upside Potential in the Healthcare Sector

iRadimed Corporation (NASDAQ: IRMD), a key player in the healthcare sector specializing in MRI-compatible medical devices, presents a compelling investment opportunity. With a market capitalization of..

Xencor, Inc. (XNCR) Stock Analysis: Unpacking a 238.94% Potential Upside in Biotechnology

For investors keen on the biotechnology sector, Xencor, Inc. (NASDAQ: XNCR) presents an intriguing proposition with a potential upside of 238.94%. This clinical-stage biopharmaceutical company, headquartered..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a Potential 143.66% Upside

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector with a focus on medical devices, is capturing investor interest with its cutting-edge ultrasound..

Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring a Potential 259% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotechnology industry, is gaining attention from investors due to its innovative approach to therapeutic protein and..

Evolus, Inc. (EOLS) Stock Analysis: A Healthcare Disruptor with 164% Upside Potential

Evolus, Inc. (NASDAQ: EOLS) is making waves in the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With its focus on the cash-pay..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 97.53% Potential Upside

For individual investors seeking opportunities in the burgeoning field of telehealth, Talkspace, Inc. (NASDAQ: TALK) presents a compelling case, particularly with its significant potential upside of..

Embecta Corp. (EMBC) Stock Analysis: Uncovering an Impressive 80% Potential Upside

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with a remarkable projected upside of..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Promising Biotech with 109% Upside Potential

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a burgeoning player in the biotechnology sector, focuses on innovative solutions for rare diseases. With a market cap of $607.49 million,..

Sionna Therapeutics, Inc. (SION): Investor Outlook on a Biotech Powerhouse with 129.71% Potential Upside

Sionna Therapeutics, Inc. (SION) is rapidly becoming a focal point for investors in the healthcare sector, particularly those with a keen interest in biotechnology. As a..

Anavex Life Sciences Corp. (AVXL): Investor Outlook with Over 200% Potential Upside

Anavex Life Sciences Corp. (AVXL), a biopharmaceutical company headquartered in New York, is making waves in the healthcare sector, particularly within the biotechnology industry. With a..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 31.94% Potential Upside Amid Diagnostics Innovation

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $523.02 million,..

CorMedix Inc. (CRMD) Stock Analysis: Exploring a 64% Potential Upside in the Biotech Sector

For investors eyeing the healthcare sector, particularly biotechnology, CorMedix Inc. (NASDAQ: CRMD) presents a compelling case with its significant potential upside of 64.03%. Specializing in biopharmaceutical..

Rocket Pharmaceuticals (RCKT) Investor Outlook: A Potential 174% Upside Despite Current Challenges

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a late-stage biotechnology company based in Cranbury, New Jersey, is making waves in the healthcare sector with its ambitious focus on..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Unveiling a 245.88% Potential Upside

Cullinan Therapeutics, Inc. (CGEM), a trailblazer in the biotechnology sector, presents an enticing opportunity for investors with a notable 245.88% potential upside. The company, headquartered in..

Weave Communications, Inc. (WEAV) Stock Analysis: A 78% Upside Potential Amidst Healthcare Innovation

Weave Communications, Inc. (NASDAQ: WEAV), a prominent player in the health information services industry, is steadily carving a niche for itself with its innovative customer experience..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Potential 100.96% Upside with Innovative Immunology Therapies

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with an impressive potential upside of 100.96%. Specializing in transformative immunology-based therapies, this clinical-stage biopharmaceutical..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Navigating Challenges with a 247% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR) stands as a compelling story in the biotechnology sector, riding the waves of a challenging market environment while offering a substantial..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds